Active Release Versus Strain-Counter-strain Technique in Patients With Non-Specific Neck Pain
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for people who have non-specific neck pain, which means neck pain without a clear cause. The trial aims to find out which treatment—Active Release Technique or Strain-Counterstrain—is better at reducing pain, improving neck movement, and helping with daily activities affected by neck pain. Both groups will also receive some common care like warm packs and gentle neck exercises. The study will take place at Safi Teaching Hospital in Pakistan and will last for four weeks.
People who might join the trial are men or women between 18 and 45 years old who have had neck pain for at least two months, with specific muscle tightness and pain points in their neck area. To be eligible, they should not have serious neck issues, nerve problems, or recent treatments like trigger point injections. If selected, participants will be randomly assigned to one of the two treatment groups and will have their pain levels, neck movement, and ability to do daily tasks measured before and after the treatment. This study hopes to help doctors understand which therapy works best to ease neck pain and improve quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-45 years
- • Both male and female
- • Patients with neck pain for at least 2 months
- • Palpable taut bands in upper trapezius, SCM
- • ATrPs in upper trapezius, levator scapulae, SCM
- • NPRS score is \>3/10 on NPRS for neck region
- • Individuals with a Craniovertebral angle less than 53
- • Individuals having grade 2 severity of neck pain according to KNGF Guidelines
- • Localized pain/stiffness in cervical spine (C3-C7) without upper limb radiculopathy
- • Diagnostic Tests: Negative Spurling's test, upper limb tension test, and shoulder abduction test
- Exclusion Criteria:
- • Myofascial treatment in the preceding month
- • Diagnosis of fibromyalgia
- • Congenital problems
- • Trigger point injections
- • Individuals with KNGF Clinical Practice Guideline Grade III and IV severity of neck pain
- • Respiratory disease and joint disease
- • Neurological deficit
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Syed Shakil ur Rehman, PhD
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported